BMRA - BIOMERICA INC
1.92
-0.050 -2.604%
Share volume: 18,674
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.97
-0.05
-0.03%
View ratios
| Fiscal Date | 11-30-2023 | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 08-31-2025 | 11-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 01-16-2024 | 04-12-2024 | 01-14-2025 | 10-15-2024 | 01-14-2025 | 04-14-2025 | 10-14-2025 | 01-14-2026 | |
| Cash flow financing | 0.000 | 0.000 | -81.000 K | 0.000 | 380.000 K | 1.736 M | 920.000 K | 482.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 77.000 K | 0.000 | 0.000 | |
| Cash flow | 0.000 | 0.000 | -1.149 M | -1.344 M | -444.000 K | 687.000 K | 652.000 K | 0.000 | |
| Net income | -1.507 M | -1.918 M | -1.421 M | -1.316 M | -950.000 K | -1.163 M | 2.000 K | -1.320 M | |
| Depreciation | 18.000 K | 20.000 K | 22.000 K | 21.000 K | 22.000 K | 21.000 K | 20.000 K | 20.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | -429.000 K | 0.000 | 0.000 | -10.000 K | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -12.000 K | -16.000 K | -24.000 K | 0.000 | -33.000 K | -4.000 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.000 K | 0.000 | 24.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -854.000 K | -1.815 M | -1.149 M | -1.350 M | -448.000 K | 686.000 K | 654.000 K | -510.000 K |